Results 151 to 160 of about 9,923 (187)

Study Design and Rationale for The Breathe Easier With Tadalafil Therapy for Exercise-Related Dyspnea in COPD-PH (BETTER COPD-PH). [PDF]

Pulm Circ
DeSanti E, Jankowich M, Choudhary G, Morrison A, Stanley ZK, Garshick E, Moy ML, Kang M, Wongtrakool C, Sadikot RT, Dempsey EC, Griffith M, Ha DM, Schmid CH, Goldstein RH, Rounds S, BETTER COPD‐PH Study Group.   +16 more
europepmc   +1 more source

Peyronie's disease in Spain: a prospective study. [PDF]

Sex Med
Peinado-Ibarra F, García-Gómez B, Alonso-Isa M, Simón-Rodríguez C, García-Cardoso J, Torremadé-Barreda J, Campos-Juanatey F, García-Baquero R, Álvarez-Maestro M, Fernández-Pascual E, Martínez-Salamanca JI, Martínez-Jabaloyas J, Rosselló-Gayá M, Chantada V, Cáceres-Rodríguez F, Sarquella J, Ruiz-Castañé E, Lledó E, Fernández-Arjona M, Fiter L, Cortiñas JR, Romero-Otero J.   +21 more
europepmc   +1 more source

Flash Pulmonary Edema Triggered by Tadalafil Use in a Patient With Chronic Left Bundle Branch Block. [PDF]

Cureus
Roytenberg R, Zamudio Herrera OR.
europepmc   +1 more source

Tadalafil Treatment in Patients With Cerebral Small Vessel Disease: The ETLAS-2 Randomized Clinical Trial. [PDF]

Stroke
Ölmestig J, Mortensen KN, Thomas MB, Fagerlund B, Naveed N, Nordling MM, Nielsen MKK, Rasmussen BS, Christensen H, Iversen HK, Poulsen MB, Siebner HR, Kruuse C.   +12 more
europepmc   +1 more source

Tadalafil Therapy for Pulmonary Arterial Hypertension

Circulation, 2009
BACKGROUND: Treatment options for pulmonary arterial hypertension target the prostacyclin, endothelin, or nitric oxide pathways. Tadalafil, a phosphodiesterase type-5 inhibitor, increases cGMP, the final mediator in the nitric oxide pathway.
Nazzareno Galie, Bruce H Brundage, Hossein A Ghofrani   +2 more
exaly   +2 more sources

Tadalafil-loaded nanostructured lipid carriers using permeation enhancers

International Journal of Pharmaceutics, 2015
© 2015 Elsevier B.V. All rights reserved. Tadalafil is a phosphodiesterase-5 inhibitor indicated for the treatment of erectile dysfunction. In this study, we prepared and evaluated transdermal nanostructured lipid carriers (NLC) to improve the skin ...
Jong-Suep Baek, Cuong Viet Pham, Chang-Seon Myung   +2 more
exaly   +1 more source